Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue

Drug Testing and Analysis

Volumn 7, Issue 2, 2015, Pages 131-142

  Sobolevsky, Tim ^a   Prasolov, Ilya ^a   Rodchenkov, Grigory ^a  

^a Moscow Antidoping Centre   (Russian Federation)

Author keywords

5F APICA; Anti doping analysis; APICA; STS 135; Synthetic cannabinoids

Indexed keywords

AMIDES; BIOMOLECULES; ELECTROSPRAY IONIZATION; HYDROXYLATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; POLYCYCLIC AROMATIC HYDROCARBONS; POSITIVE IONS;

5F-N-(1-ADAMANTYL)-1-PENTYL-1H-INDOLE-3-CARBOXAMIDE; ANTI-DOPING ANALYSE; CARBOXAMIDES; DOPING ANALYSIS; IN-VITRO; N-(1-ADAMANTYL)-1-PENTYL-1H-INDOLE-3-CARBOXAMIDE; STS-135; SYNTHETIC CANNABINOID;

METABOLITES;

CANNABINOID DERIVATIVE; N (1 ADAMANTYL) 1 (5 FLUOROPENTYL) 1H INDOLE 3 CARBOXAMIDE; N (1 ADAMANTYL) 1 PENTYL 1H INDOLE 3 CARBOXAMIDE; UNCLASSIFIED DRUG; ADAMANTANE; CANNABINOID; INDOLE DERIVATIVE; N-(ADAMTAN-1-YL)-1-PENTYL-1H-INDOLE-3-CARBOXAMIDE; STREET DRUG;

ARTICLE; DEFLUORINATION; DRUG ISOLATION; DRUG METABOLISM; DRUG USE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; METABOLITE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; URINALYSIS; ANALOGS AND DERIVATIVES; CHEMISTRY; HALOGENATION; MASS FRAGMENTOGRAPHY; METABOLISM; TANDEM MASS SPECTROMETRY; URINE;

ADAMANTANE; CANNABINOIDS; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALOGENATION; HUMANS; INDOLES; MICROSOMES, LIVER; STREET DRUGS; TANDEM MASS SPECTROMETRY;

EID: 84922013603     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1756     Document Type: Article

References (45)

1. N. Langer, R. Lindigkeit, H.M. Schiebel, L. Ernst, T. Beuerle. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: A snapshot of the German situation in the autumn of 2012. Drug Test. Anal. 2014, 6, 59.
2. K.G. Shanks, G.S. Behonick, T. Dahn, A. Terrell. Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry. J. Anal. Toxicol. 2013, 37, 517.
3. K.G. Shanks, T. Dahn, G.S. Behonick, A. Terrell. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. J. Anal. Toxicol. 2012, 36, 360.
4. K. Simolka, R. Lindigkeit, H.M. Schiebel, U. Papke, L. Ernst, T. Beuerle. Analysis of synthetic cannabinoids in " spice-like" herbal highs: Snapshot of the German market in summer 2011. Anal. Bioanal. Chem. 2012, 404, 157.
5. World Anti-Doping Agency. The 2014 Prohibited List. International Standard. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2014/WADA-prohibited-list-2014-EN.pdf [11 April 2014].
6. S. Kneisel, V. Auwärter, J. Kempf. Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry. Drug Test. Anal. 2013, 5, 657.
7. E.L. Oiestad, U. Johansen, A.S. Christophersen, R. Karinen. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS. Bioanalysis 2013, 5, 2257.
8. M. Hutter, S. Kneisel, V. Auwärter, M.A. Neukamm. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2012, 903, 95.
9. S. Kneisel, V. Auwärter. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 2012, 47, 825.
10. R. Kronstrand, M. Roman, M. Andersson, A. Eklund. Toxicological findings of synthetic cannabinoids in recreational users. J. Anal. Toxicol. 2013, 37, 534.
11. T. Sobolevsky, I. Prasolov, G. Rodchenkov. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci. Int. 2010, 200, 141.
12. A. Wohlfarth, K.B. Scheidweiler, X. Chen, H.F. Liu, M.A. Huestis. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Anal. Chem. 2013, 85, 3730.
13. P. Kavanagh, A. Grigoryev, A. Melnik, A. Simonov. The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry. J. Anal. Toxicol. 2012, 36, 303.
14. M. Hutter, B. Moosmann, S. Kneisel, V. Auwärter. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J. Mass Spectrom. 2013, 48, 885.
15. P. Kavanagh, A. Grigoryev, A. Melnik, S. Savchuk, A. Simonov, V. Rozhanets. Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS/MS. J. Chromatogr. B 2013, 934, 102.
16. A. Wohlfarth, S. Pang, M. Zhu, A.S. Gandhi, K.B. Scheidweiler, H.F. Liu, M.A. Huestis. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clin. Chem. 2013, 59, 1638.
17. P. Adamowicz, D. Zuba, K. Sekul a. Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine. Forensic Sci. Int. 2013, 233, 320.
18. T. Sobolevsky, I. Prasolov, G. Rodchenkov. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test. Anal. 2012, 4, 745.
19. A. Grigoryev, A. Melnik, S. Savchuk, A. Simonov, V. Rozhanets. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. J. Chromatogr. B 2011, 879, 2519.
20. A. Grigoryev, P. Kavanagh, A. Melnik. The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography - mass spectrometry. Drug Test. Anal. 2013, 5, 110.
21. A. Grigoryev, P. Kavanagh, A. Melnik, S. Savchuk, A. Simonov. Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product. J. Anal. Toxicol. 2013, 37, 265.
22. V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz, N. Ferreirós. "Spice" and other herbal blends: Harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 2009, 44, 832.
23. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara, Y. Goda. Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol. 2009, 27, 61.
24. B.K. Logan, L.E. Reinhold, A. Xu, F.X. Diamond. Identification of synthetic cannabinoids in herbal incense blends in the United States. J. Forensic Sci. 2012, 57, 1168.
25. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, Y. Goda. Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicol. 2012, 30, 114.
26. M. Bononi, P. Belgi, F. Tateo. Analytical data for identification of the Cannabimimetic Phenylacetylindole JWH-203. J. Anal. Toxicol. 2011, 35, 360.
27. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, Y. Goda. Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol. 2011, 29, 25.
28. 2 receptors. Chem. Pharm. Bull. (Tokyo) 2011, 59, 1203.
29. R. Denooz, J.C. Vanheugen, M. Frederich, P. de Tullio, C. Charlier. Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products. J. Anal. Toxicol. 2013, 37, 56.
30. L. Ernst, K. Krüger, R. Lindigkeit, H.M. Schiebel, T. Beuerle. Synthetic cannabinoids in " spice-like" herbal blends: First appearance of JWH-307 and recurrence of JWH-018 on the German market. Forensic Sci. Int. 2012, 222, 216.
31. P. Kavanagh, A. Grigoryev, S. Savchuk, I. Mikhura, A. Formanovsky. UR-144 in products sold via the Internet: Identification of related compounds and characterization of pyrolysis products. Drug Test. Anal. 2013, 5, 683.
32. F. Westphal, U. Girreser, S. Knecht. Structure elucidation of a new open chain isomer of the cannabimimetic cyclopropoylindole A-796, 260. Forensic Sci. Int. 2014, 234, 139.
33. N. Uchiyama, S. Matsuda, M. Kawamura, R. Kikura-Hanajiri, Y. Goda. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol. 2013, 3, 223.
34. N. Uchiyama, S. Matsuda, D. Wakana, R. Kikura-Hanajiri, Y. Goda. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products. Forensic Toxicol. 2013, 31, 93.
35. N. Uchiyama, Y. Shimokawa, S. Matsuda, M. Kawamura, R. Kikura-Hanajiri, Y. Goda. Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3, 4, 5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products. Forensic Toxicol. 2014, 32, 105.
36. P. Kavanagh, P. Spiers, J. O'Brien, S. McNamara, D. Angelov, D. Mullan, B. Talbot, S. Ryder. Head shop "legal highs" active constituents identification chart, July-August 2010, 714-823. Available at: http://www.drugsandalcohol.ie/13972/1/Head_shops_identification_July_Aug_2010.pdf [11 April 2014].
37. S. Kneisel, F. Westphal, P. Bisel, V. Brecht, S. Broecker, V. Auwärter. Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in "herbal incense". J. Mass Spectrom. 2012, 47, 195.
38. A. Grigoryev, P. Kavanagh, A. Melnik. The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry. Drug Test. Anal. 2012, 4, 519.
39. A.S. Gandhi, M. Zhu, S. Pang, A. Wohlfarth, K.B. Scheidweiler, H.F. Liu, M.A. Huestis. First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. AAPS J. 2013, 15, 1091.
40. A.S. Gandhi, A. Wohlfarth, M. Zhu, S. Pang, M. Castaneto, K.B. Scheidweiler, M.A. Huestis. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes. Drug Test. Anal. 2014. DOI: 10.1002/dta.1662
41. S.D. Banister, S.M. Wilkinson, M. Longworth, J. Stuart, N. Apetz, K. English, L. Brooker, C. Goebel, D.E. Hibbs, M. Glass, M. Connor, I.S. McGregor, M. Kassiou. The synthesis and pharmacological evaluation of adamantane derived indoles: Cannabimimetic drugs of abuse. ACS Chem. Neurosci. 2013, 4, 1081.
42. Cayman Spectral Library. Release Date 11-26-13. Available at: https://www.caymanchem.com/app/template/SpectralLibrary.vm [11 April 2014].
43. SWGDRUG. Scientific Working Group for the Analysis of Seized Drugs. Available at: http://www.swgdrug.org [11 August 2014].
44. G. Merola, Z. Aturki, G. D'Orazio, R. Gottardo, T. Macchia, F. Tagliaro, S. Fanali. Analysis of synthetic cannabinoids in herbal blends by means of nano-liquid chromatography. J. Pharmaceut. Biomed. 2012, 71, 45.
45. Drug Metabolism: Current Concepts. (Eds: C. Ionescu, M.R. Caira ), Springer, Dordrecht, 2005, pp. 115.